Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Comment
. 2013 Jul 12;16(1):18756.
doi: 10.7448/IAS.16.1.18756.

When to start ART in Africa--primarily guided by RCTs or patient autonomy?

Affiliations
Comment

When to start ART in Africa--primarily guided by RCTs or patient autonomy?

Wim Delva et al. J Int AIDS Soc. .
No abstract available

PubMed Disclaimer

Comment on

References

    1. De Cock KM, El-Sadr WM. When to start ART in Africa – an urgent research priority. N Engl J Med. 2013;368:886–9. - PMC - PubMed
    1. Gupta S, Granich R, Suthar AB, Smyth C, Baggaley R, Sculier D, et al. Global policy review of ART eligibility criteria for treatment and prevention of HIV and TB in adults, pregnant women, and serodiscordant couples: ART recommendations by national guidelines. J Acquir Immune Defic Syndr. 2012;62(3):e87–e97. - PubMed
    1. Mnyani CN. Cape Town; 2012. Overview of options A, B, and B+ for PMTCT. SA HIV Clinicians Society Conference 2012; Nov 25–28.
    1. Anglaret X, Minga A, Gabillard D, Ouassa T, Messou E, Morris B, et al. AIDS and non-AIDS morbidity and mortality across the spectrum of CD4 cell counts in HIV-infected adults before starting antiretroviral therapy in Cote d'Ivoire. Clin Infect Dis. 2012;54(5):714–23. - PMC - PubMed
    1. Gabillard D, Lewden C, Ndoye I, Moh R, Segeral O, Tonwe-Gold B, et al. Mortality, AIDS-morbidity and loss to follow-up by current CD4 cell count among HIV-1 infected adults receiving antiretroviral therapy in Africa and Asia: data from the ANRS 12222 collaboration. J Acquir Immune Defic Syndr. 2012;62(5):555–61. - PMC - PubMed

MeSH terms

Substances

LinkOut - more resources